Stephanie Saw

Dr. Stephanie P.L. Saw is a consultant medical oncologist in the thoracic oncology group at the National Cancer Centre Singapore and an Assistant Professor in the SingHealth Duke-NUS Oncology Academic Clinical Programme. Her research focuses on precision oncology in EGFR-mutated non-small cell lung cancer, including improving risk stratification, for which she earned a PhD from Duke-NUS in 2025 and was awarded an NMRC Transition Award. She co-authored the Asian Thoracic Oncology Research Group consensus on peri-operative management of non-small cell lung cancer and speaks regularly at international congresses including ASCO.